Aptar Releases 2025 Corporate Sustainability Report
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Releases 2025 Corporate Sustainability Report.
Business Wire6/18/2026Neutral
ATR
AptarGroup IncNYSEHEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES
Key Statistics
Market Cap
$7.93B
P/E Ratio
21.27
EPS
$5.84
Beta
0.39
52W High
$162.40
52W Low
$102.43
50-Day MA
$119.45
200-Day MA
$125.35
Dividend Yield
1.46%
Profit Margin
9.98%
Forward P/E
16.47
PEG Ratio
2.29
About AptarGroup Inc
AptarGroup, Inc. offers a range of packaging, dispensing and sealing solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectables, and food and beverage markets. The company is headquartered in Crystal Lake, Illinois.
Fundamentals
| Revenue (TTM) | $3.87B |
| Gross Profit (TTM) | $1.42B |
| EBITDA | $806.60M |
| Operating Margin | 11.10% |
| Return on Equity | 14.80% |
| Return on Assets | 6.61% |
| Revenue/Share (TTM) | $59.41 |
| Book Value | $41.15 |
| Price-to-Book | 3.08 |
| Price-to-Sales (TTM) | 2.05 |
| EV/Revenue | 2.397 |
| EV/EBITDA | 11.12 |
| Quarterly Earnings Growth (YoY) | -4.30% |
| Quarterly Revenue Growth (YoY) | 10.80% |
| Shares Outstanding | $63.82M |
| Float | $63.20M |
| % Insiders | 0.88% |
| % Institutions | 97.06% |
Historical Volatility
HV 10-Day
25.57%
HV 20-Day
23.36%
HV 30-Day
22.42%
HV 60-Day
24.34%
HV Rank
37.3%
Volatility is currently expanding
Analyst Ratings
Consensus ($160.43 target)
2
Strong Buy4
Buy2
HoldLatest News
AptarGroup, Inc. (ATR) Presents at 16th Annual Wells Fargo Industrials & Materials Conference Transcript
AptarGroup, Inc. (ATR) Presents at 16th Annual Wells Fargo Industrials & Materials Conference Transcript
Seeking Alpha6/10/2026Neutral
AptarGroup, Inc. (ATR) Presents at Jefferies Global Healthcare Conference 2026 Transcript
AptarGroup, Inc. (ATR) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Seeking Alpha6/3/2026Neutral
Aptar Named a CDP Supplier Engagement Leader for the Sixth Consecutive Year
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Named a CDP Supplier Engagement Leader for the Sixth Consecutive Year.
Business Wire6/2/2026Neutral
AptarGroup Q1 Earnings Beat Estimates but Decline Y/Y, Shares Dip 1%
ATR tops Q1 earnings estimates on strong sales growth, but profit declines, pharma headwinds and margin pressure send shares down despite an upbeat Q2 outlook.
Zacks Investment Research5/6/2026Positive
Advanced Technology Recycling (ATR) Announces That They Are Now Offering Wholesale Electronics to the General Public Through Their Online Auction Site
ITAD Firm, Advanced Technology Recycling (ATR), now offers wholesale electronics and computers to the general public through our online auction platform.
GlobeNewsWire5/4/2026Neutral
Avery Dennison Q1 Earnings Top Estimates on Volume Gains, Cost Control
AVY beats Q1 earnings estimates on strong volumes and cost control, with profits rising and cash flow swinging to positive despite mixed segment performance.
Zacks Investment Research4/28/2026Positive
Analysts Estimate Graphic Packaging (GPK) to Report a Decline in Earnings: What to Look Out for
Graphic Packaging (GPK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks Investment Research4/28/2026Negative
Earnings Preview: AptarGroup (ATR) Q1 Earnings Expected to Decline
AptarGroup (ATR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks Investment Research4/23/2026Negative
Aptar Digital Health Partners with Enable Injections for enFuse® Companion Digital Solution
CINCINNATI, April 08, 2026 (GLOBE NEWSWIRE) -- Aptar Digital Health, a global leader in digital health solutions enhancing the patient experience, and Enable Injections, Inc. (“Enable”), a healthcare innovation company developing and manufacturing the enFuse® On-Body Delivery System, today announced a strategic partnership naming Aptar Digital Health as Enable's preferred digital health partner for the enFuse® system. This digital solution will be designed to guide patients and caregivers throughout the injection process and help strengthen engagement support before, during and after administration.
GlobeNewsWire4/8/2026Neutral
More HEALTHCARE Stocks
Data last updated: 7/9/2026